1. Home
  2. COCP vs MOB Comparison

COCP vs MOB Comparison

Compare COCP & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • MOB
  • Stock Information
  • Founded
  • COCP N/A
  • MOB 2008
  • Country
  • COCP United States
  • MOB Israel
  • Employees
  • COCP N/A
  • MOB N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • MOB Real Estate Investment Trusts
  • Sector
  • COCP Health Care
  • MOB Real Estate
  • Exchange
  • COCP Nasdaq
  • MOB Nasdaq
  • Market Cap
  • COCP 15.3M
  • MOB 15.8M
  • IPO Year
  • COCP N/A
  • MOB 2022
  • Fundamental
  • Price
  • COCP $1.36
  • MOB $1.63
  • Analyst Decision
  • COCP Strong Buy
  • MOB
  • Analyst Count
  • COCP 1
  • MOB 0
  • Target Price
  • COCP $7.00
  • MOB N/A
  • AVG Volume (30 Days)
  • COCP 17.0K
  • MOB 104.6K
  • Earning Date
  • COCP 03-31-2025
  • MOB 04-11-2025
  • Dividend Yield
  • COCP N/A
  • MOB N/A
  • EPS Growth
  • COCP N/A
  • MOB N/A
  • EPS
  • COCP N/A
  • MOB N/A
  • Revenue
  • COCP N/A
  • MOB $3,638,054.00
  • Revenue This Year
  • COCP N/A
  • MOB N/A
  • Revenue Next Year
  • COCP N/A
  • MOB N/A
  • P/E Ratio
  • COCP N/A
  • MOB N/A
  • Revenue Growth
  • COCP N/A
  • MOB 35.53
  • 52 Week Low
  • COCP $1.35
  • MOB $0.71
  • 52 Week High
  • COCP $3.26
  • MOB $5.00
  • Technical
  • Relative Strength Index (RSI)
  • COCP 31.02
  • MOB 35.12
  • Support Level
  • COCP $1.38
  • MOB $1.50
  • Resistance Level
  • COCP $1.49
  • MOB $1.80
  • Average True Range (ATR)
  • COCP 0.09
  • MOB 0.20
  • MACD
  • COCP -0.01
  • MOB -0.05
  • Stochastic Oscillator
  • COCP 0.00
  • MOB 8.82

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers.

Share on Social Networks: